molgramostim
Sign in to saveMolgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.
Research
96 papers- Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.The New England journal of medicine · 2020
- Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis.The New England journal of medicine · 2025
- Inhaled molgramostim therapy for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP): a plain language summary of the IMPALA trial.Hospital practice (1995) · 2024
- Pharmacokinetics and pharmacodynamics of inhaled molgramostim in healthy people.BMJ open respiratory research · 2025
- New emerging applications of molgramostim in acute myeloid leukaemia.Expert opinion on drug metabolism & toxicology · 2008
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Molgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.
==References==
Excerpted from Wikipedia’s “molgramostim” article, available under the CC BY-SA 4.0 licence.